Alba Matas‐Céspedes

530 total citations
19 papers, 370 citations indexed

About

Alba Matas‐Céspedes is a scholar working on Immunology, Genetics and Oncology. According to data from OpenAlex, Alba Matas‐Céspedes has authored 19 papers receiving a total of 370 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 9 papers in Genetics and 8 papers in Oncology. Recurrent topics in Alba Matas‐Céspedes's work include Chronic Lymphocytic Leukemia Research (9 papers), Lymphoma Diagnosis and Treatment (7 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). Alba Matas‐Céspedes is often cited by papers focused on Chronic Lymphocytic Leukemia Research (9 papers), Lymphoma Diagnosis and Treatment (7 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). Alba Matas‐Céspedes collaborates with scholars based in Spain, United States and Netherlands. Alba Matas‐Céspedes's co-authors include Patricia Pérez‐Galán, Dolors Colomer, Elı́as Campo, Gaël Roué, Kourosh Saeb‐Parsy, Vanina Rodríguez, Armando López‐Guillermo, Neus Villamor, Nikitas Georgakopoulos and Laia Rosich and has published in prestigious journals such as Blood, Cancer Research and Clinical Cancer Research.

In The Last Decade

Alba Matas‐Céspedes

18 papers receiving 366 citations

Peers

Countries citing papers authored by Alba Matas‐Céspedes

Since Specialization

Citations

This map shows the geographic impact of Alba Matas‐Céspedes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alba Matas‐Céspedes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alba Matas‐Céspedes more than expected).

Fields of papers citing papers by Alba Matas‐Céspedes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alba Matas‐Céspedes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alba Matas‐Céspedes. The network helps show where Alba Matas‐Céspedes may publish in the future.

Co-authorship network of co-authors of Alba Matas‐Céspedes

This figure shows the co-authorship network connecting the top 25 collaborators of Alba Matas‐Céspedes. A scholar is included among the top collaborators of Alba Matas‐Céspedes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alba Matas‐Céspedes. Alba Matas‐Céspedes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Characterization of a novel potency endpoint for the evaluation of immune checkpoint blockade in humanized mice 2023 ·Frontiers in Immunology ·Alba Matas‐Céspedes, Jean‐Martin Lapointe, Matthew J. Elder, Gareth J. Browne, Simon J. Dovedi, Lolke de Haan, (unknown), Richard Stebbings	0
2	3D Model Characterization by 2D and 3D Imaging in t(14;18)-Positive B-NHL: Perspectives for In Vitro Drug Screens in Follicular Lymphoma 2021 ·Cancers ·(unknown), (unknown), Pauline Gravelle, Juan García Valero, (unknown), Renaud Morin, (unknown), (unknown), Jean‐Michel Lagarde, Cédric Rossi, (unknown), (unknown), Jacques Rouquette, Alba Matas‐Céspedes, Jean‐Jacques Fournié, Loïc Ysebaert, Camille Laurent, Patricia Pérez‐Galán, Christine Bezombes	9
3	The receptor of the colony-stimulating factor-1 (CSF-1R) is a novel prognostic factor and therapeutic target in follicular lymphoma 2021 ·Leukemia ·Juan García Valero, Alba Matas‐Céspedes, Fabián Arenas, Vanina Rodríguez, Joaquim Carreras, Neus Serrat, (unknown), (unknown), Olga Balagué, Silvia Martín, (unknown), Luís Hernández, Laura Magnano, Alfredo Rivas‐Delgado, Stacey Tannheimer, María C. Cid, Elı́as Campo, Armando López‐Guillermo, Dolors Colomer, Patricia Pérez‐Galán	52
4	Modeling human tumor-immune environments in vivo for the preclinical assessment of immunotherapies 2021 ·Cancer Immunology Immunotherapy ·(unknown), Nikitas Georgakopoulos, Alba Matas‐Céspedes, (unknown), Kourosh Saeb‐Parsy	40
5	Use of human splenocytes in an innovative humanised mouse model for prediction of immunotherapy‐induced cytokine release syndrome 2020 ·Clinical & Translational Immunology ·Alba Matas‐Céspedes, Lee R. Brown, Krishnaa T. Mahbubani, (unknown), (unknown), (unknown), Lolke de Haan, Jean‐Martin Lapointe, Richard Stebbings, Kourosh Saeb‐Parsy	15
6	Daratumumab displays in vitro and in vivo anti-tumor activity in models of B-cell non-Hodgkin lymphoma and improves responses to standard chemo-immunotherapy regimens 2019 ·Haematologica ·(unknown), Alba Matas‐Céspedes, Vanina Rodríguez, Cédric Rossi, Juan García Valero, Neus Serrat, Alejandra Sanjuán-Pla, Pablo Menéndez, Gaël Roué, Armando López‐Guillermo, Eva Giné, Elı́as Campo, Dolors Colomer, Christine Bezombes, Jeroen Lammerts van Bueren, Christopher Chiu, Parul Doshi, Patricia Pérez‐Galán	32
7	Recent Advancements and Applications of Human Immune System Mice in Preclinical Immuno-Oncology 2019 ·Toxicologic Pathology ·(unknown), Maelle Mairesse, Alba Matas‐Céspedes, (unknown), Giovanni Pellegrini, (unknown), (unknown), (unknown), (unknown), Richard Stebbings, Catherine J. Betts, Kourosh Saeb‐Parsy	17
8	DECIPHERING THE CONTRIBUTION OF MACROPHAGES TO FOLLICULAR LYMPHOMA PATHOGENESIS: NEW INSIGHTS INTO THERAPY 2019 ·Hematological Oncology ·(unknown), Juan García Valero, Alba Matas‐Céspedes, Vanina Rodríguez, Fabián Arenas, Joaquim Carreras, Neus Serrat, (unknown), (unknown), (unknown), Silvia Martín, Alfredo Rivas‐Delgado, Stacey Tannheimer, María C. Cid, Elı́as Campo, Armando López‐Guillermo, Dolors Colomer	2
9	Boosting γδ T cell-mediated antibody-dependent cellular cytotoxicity by PD-1 blockade in follicular lymphoma 2018 ·OncoImmunology ·Cédric Rossi, Pauline Gravelle, (unknown), (unknown), Mary Poupot, Marie Tosolini, Don‐Marc Franchini, Camille Laurent, Renaud Morin, Jean‐Michel Lagarde, Loïc Ysebaert, Lætitia Ligat, Christine Jean, Ariel Savina, Christian Klein, Alba Matas‐Céspedes, Patricia Pérez‐Galán, Jean‐Jacques Fournié, Christine Bezombes	50
10	Activity of the novel BCR kinase inhibitor IQS019 in preclinical models of B-cell non-Hodgkin lymphoma 2017 ·Journal of Hematology & Oncology ·Patricia Balsas, (unknown), (unknown), (unknown), Vanina Rodríguez, Juan García Valero, Aránzazu Chamorro-Jorganes, Raimon Puig de la Bellacasa, Jordi Teixidó, Alba Matas‐Céspedes, Alexandra Moros, Antonio Martı́nez, Elı́as Campo, Andrea Sáez‐Borderías, José I. Borrell, Patricia Pérez‐Galán, Dolors Colomer, Gaël Roué	7
11	ANTI‐TUMOR ACTIVITY OF DARATUMUMAB, A NOVEL HUMAN ANTI CD38 MONOCLONAL ANTIBODY, IN IN VITRO AND IN VIVO MODELS OF B‐CELL NON‐HODGKIN LYMPHOMA 2017 ·Hematological Oncology ·Patricia Pérez‐Galán, (unknown), Alba Matas‐Céspedes, Vanina Rodríguez, Cynthia A. Rossi, Gaël Roué, Armando López‐Guillermo, Eva Giné, Elı́as Campo, Dolors Colomer, Adrian Wiestner, Christine Bezombes, (unknown), Christopher Chiu, Parul Doshi	1
12	The Human CD38 Monoclonal Antibody Daratumumab Shows Antitumor Activity and Hampers Leukemia–Microenvironment Interactions in Chronic Lymphocytic Leukemia 2016 ·Clinical Cancer Research ·Alba Matas‐Céspedes, (unknown), Vanina Rodríguez, Neus Villamor, Julio Delgado, Eva Giné, Heleia Roca-Ho, Pablo Menéndez, Elı́as Campo, Armando López‐Guillermo, Dolors Colomer, Gaël Roué, Adrian Wiestner, Paul W.H.I. Parren, Parul Doshi, Jeroen Lammerts van Bueren, Patricia Pérez‐Galán	45
13	Disruption of Follicular Dendritic Cells–Follicular Lymphoma Cross-talk by the Pan-PI3K Inhibitor BKM120 (Buparlisib) 2014 ·Clinical Cancer Research ·Alba Matas‐Céspedes, Vanina Rodríguez, Susana G. Kalko, (unknown), Laia Rosich, (unknown), Patricia Balsas, Neus Villamor, Eva Giné, Elı́as Campo, Gaël Roué, Armando López‐Guillermo, Dolors Colomer, Patricia Pérez‐Galán	21
14	The γ-secretase inhibitor PF-03084014 combined with fludarabine antagonizes migration, invasion and angiogenesis in NOTCH1-mutated CLL cells 2014 ·Leukemia ·Mònica López‐Guerra, Sílvia Xargay‐Torrent, Laia Rosich, Arnau Montraveta, (unknown), Alba Matas‐Céspedes, Neus Villamor, Marta Aymerich, Carlos López-Otı́n, Patricia Pérez‐Galán, Gaël Roué, Elı́as Campo, Dolors Colomer	55
15	Daratumumab, a Novel Anti-CD38 Monoclonal Antibody Shows Anti-Tumor Activity in CLL and hampers Leukemia-Microenvironment Interactions 2014 ·Blood ·Alba Matas‐Céspedes, (unknown), Vanina Rodríguez, Julio Delgado, Neus Villamor, Gaël Roué, Elı́as Campo, Dolors Colomer, Parul Doshi, Adrian Wiestner, Paul W.H.I. Parren, Jeroen Lammerts van Bueren, Patricia Pérez‐Galán	5
16	Abstract 1757: The novel BTK inhibitor CC-292 exerts in vitro and in vivo antitumor activity, interferes with adhesion, cell migration, and synergizes with lenalidomide in MCL models 2014 ·Cancer Research ·(unknown), Vanina Rodríguez, Alba Matas‐Céspedes, (unknown), Armando López‐Guillermo, Gaël Roué, Dolors Colomer, Patricia Pérez‐Galán	2
17	Daratumumab, a Novel Human Anti-CD38 Monoclonal antibody shows Anti-Tumor Activity In Mouse Models Of MCL, FL and CLL 2013 ·Blood ·Alba Matas‐Céspedes, Anna Vidal Crespo, Vanina Rodríguez, Gaël Roué, Armando López‐Guillermo, Elı́as Campo, Dolors Colomer, Jeroen Lammerts van Bueren, Joost M. Bakker, Adrian Wiestner, Paul W.H.I. Parren, Patricia Pérez‐Galán	6
18	Follicular Dendrytic Cells Deliver Angiogenesis Signaling To Follicular Lymphoma Cells That Is Hampered By The Pan-PI3K Inhibitor NVP-BKM120 2013 ·Blood ·Alba Matas‐Céspedes, Vanina Rodríguez, Susana G. Kalko, Eva Giné, Elı́as Campo, Gaël Roué, Armando López‐Guillermo, Dolors Colomer, Patricia Pérez‐Galán	2
19	Daratumumab, a Novel Human Anti-CD38 Monoclonal Antibody for the Treatment of Chronic Lymphocytic Leukemia and B-Cell Non–Hodgkin Lymphoma 2012 ·Blood ·Alba Matas‐Céspedes, (unknown), Vanina Rodríguez, Gaël Roué, Elı́as Campo, Dolors Colomer, Jeroen Lammerts van Bueren, Joost M. Bakker, Adrian Wiestner, Paul W.H.I. Parren, Patricia Pérez‐Galán	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact